US Stock MarketDetailed Quotes

CHRS Coherus BioSciences

Watchlist

2.155
+0.075+3.61%

Trading May 15 15:31 ET

247.23MMarket Cap-2912P/E (TTM)

Coherus BioSciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

31.96%-46.77M

27.47%-174.88M

87.06%-12.94M

-46.40%-54.3M

22.23%-38.92M

-27.18%-68.73M

-544.17%-241.12M

-91.03%-99.95M

-370.51%-37.09M

-26,515.43%-50.04M

Net income from continuing operations

235.85%102.88M

18.46%-237.89M

-35.30%-79.65M

54.25%-39.64M

14.52%-42.87M

21.18%-75.73M

-1.62%-291.75M

-28.75%-58.87M

-124.90%-86.65M

-67.73%-50.15M

Operating gains losses

---153.65M

----

--6.22M

--0

Depreciation and amortization

58.80%1.51M

2.49%3.79M

1.24%1.06M

-9.65%899K

-0.79%880K

23.73%949K

7.09%3.7M

25.60%1.05M

11.55%995K

1.14%887K

Other non cash items

-1,989.15%-2.7M

-92.29%3.39M

-67.86%477K

-22.33%1.24M

13.15%1.81M

-100.33%-129K

-69.27%43.96M

24.29%1.48M

-16.23%1.59M

122.75%1.6M

Change In working capital

-21.74%-11.38M

53.54%-36.83M

111.66%6.37M

-417.69%-27.62M

61.60%-6.23M

45.40%-9.35M

-287.10%-79.26M

-165.00%-54.61M

-73.10%8.69M

-166.87%-16.22M

-Change in receivables

0.59%8.58M

-1,254.48%-150.68M

-134.38%-44.06M

-406.97%-75.28M

-3,084.96%-39.88M

42.36%8.53M

-61.68%13.05M

-240.91%-18.8M

347.56%24.52M

194.08%1.34M

-Change in inventory

-328.87%-11.46M

1.30%-46.73M

-20.44%-11.79M

17.67%-19.23M

-16.04%-13.04M

9.82%-2.67M

-657.20%-47.35M

-6.56%-9.79M

-443.63%-23.35M

-249.52%-11.24M

-Change in prepaid assets

31.78%5.16M

203.08%18.18M

83.46%3.37M

149.25%9.72M

-84.72%1.17M

153.06%3.92M

-1,058.11%-17.64M

-69.11%1.84M

-215.74%-19.74M

492.64%7.65M

-Change in payables and accrued expense

35.98%-12.24M

621.21%142.41M

311.21%58.85M

109.62%57.16M

425.95%45.53M

-49.84%-19.12M

-269.98%-27.32M

9.28%-27.86M

3.70%27.27M

-182.79%-13.97M

-Change in other working capital

---1.42M

----

Cash from discontinued investing activities

Operating cash flow

31.96%-46.77M

27.47%-174.88M

87.06%-12.94M

-46.40%-54.3M

22.23%-38.92M

-27.18%-68.73M

-544.17%-241.12M

-91.03%-99.95M

-370.51%-37.09M

-26,515.43%-50.04M

Investing cash flow

Cash flow from continuing investing activities

1,056.93%202.76M

186.69%144.64M

127.10%35.2M

11,160.39%50.55M

4,800.57%41.37M

149.21%17.53M

-20.55%-166.85M

-220.85%-129.9M

-102.86%-457K

-103.73%-880K

Net PPE purchase and sale

----

127.42%559K

148.28%42K

133.04%151K

----

-58.18%-2.04M

81.41%-87K

-75.10%-457K

-112.05%-880K

Net business purchase and sale

----

--7M

--0

----

--0

----

Net investment purchase and sale

-14.93%14.89M

208.44%138.14M

128.43%36.21M

--43.4M

--41.03M

--17.5M

-11,263.25%-127.38M

-217.99%-127.38M

--0

Net other investing changes

722,496.15%187.88M

97.19%-1.05M

----

100.07%26K

72.48%-37.43M

---2.43M

--0

Cash from discontinued investing activities

Investing cash flow

1,056.93%202.76M

186.69%144.64M

127.10%35.2M

11,160.39%50.55M

4,800.57%41.37M

149.21%17.53M

-20.55%-166.85M

-220.85%-129.9M

-102.86%-457K

-103.73%-880K

Financing cash flow

Cash flow from continuing financing activities

-76.68%887K

28.12%69.6M

-94.45%366K

-77.28%11.11M

7,434.67%54.33M

305.07%3.8M

4.72%54.33M

343.38%6.59M

4,338.42%48.87M

-98.46%721K

Net issuance payments of debt

----

--0

----

--49.93M

--0

--49.49M

--0

Net common stock issuance

-77.95%1.51M

1,028.00%71.72M

-101.65%-105K

--11.44M

--53.55M

--6.84M

-84.46%6.36M

--6.36M

--0

Proceeds from stock option exercised by employees

182.52%291K

-16.87%2.5M

37.38%996K

-32.91%53K

-18.76%1.35M

-81.07%103K

-77.53%3.01M

-57.10%725K

-93.83%79K

-72.75%1.66M

Net other financing activities

70.93%-911K

7.06%-4.62M

-7.14%-525K

45.08%-385K

38.75%-577K

-10.39%-3.13M

-105.03%-4.97M

-141.38%-490K

-291.62%-701K

-515.69%-942K

Cash from discontinued financing activities

Financing cash flow

-76.68%887K

28.12%69.6M

-94.45%366K

-77.28%11.11M

7,434.67%54.33M

305.07%3.8M

4.72%54.33M

343.38%6.59M

4,338.42%48.87M

-98.46%721K

Net cash flow

Beginning cash position

61.51%103.34M

-84.68%63.99M

-71.90%80.71M

-73.41%73.36M

-94.91%16.59M

-84.68%63.99M

-22.89%417.64M

-20.43%287.25M

-16.43%275.92M

25.47%326.12M

Current changes in cash

430.96%156.88M

111.13%39.36M

110.14%22.63M

-35.07%7.35M

213.11%56.78M

48.20%-47.4M

-185.29%-353.65M

-494.07%-223.26M

-63.25%11.32M

-171.45%-50.2M

End cash Position

1,469.05%260.23M

61.51%103.34M

-71.90%80.71M

-73.41%73.36M

-94.91%16.59M

-84.68%63.99M

-20.43%287.25M

-16.43%275.92M

Free cash flow

31.96%-46.77M

27.96%-175.17M

87.03%-12.97M

-44.62%-54.3M

23.08%-39.17M

-25.74%-68.73M

-527.99%-243.16M

-89.51%-100.04M

-379.15%-37.55M

-8,343.95%-50.92M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	31.96%-46.77M	27.47%-174.88M	87.06%-12.94M	-46.40%-54.3M	22.23%-38.92M	-27.18%-68.73M	-544.17%-241.12M	-91.03%-99.95M	-370.51%-37.09M	-26,515.43%-50.04M
Net income from continuing operations	235.85%102.88M	18.46%-237.89M	-35.30%-79.65M	54.25%-39.64M	14.52%-42.87M	21.18%-75.73M	-1.62%-291.75M	-28.75%-58.87M	-124.90%-86.65M	-67.73%-50.15M
Operating gains losses	---153.65M	----	----	----	----	----	--6.22M	--0	--0	--0
Depreciation and amortization	58.80%1.51M	2.49%3.79M	1.24%1.06M	-9.65%899K	-0.79%880K	23.73%949K	7.09%3.7M	25.60%1.05M	11.55%995K	1.14%887K
Other non cash items	-1,989.15%-2.7M	-92.29%3.39M	-67.86%477K	-22.33%1.24M	13.15%1.81M	-100.33%-129K	-69.27%43.96M	24.29%1.48M	-16.23%1.59M	122.75%1.6M
Change In working capital	-21.74%-11.38M	53.54%-36.83M	111.66%6.37M	-417.69%-27.62M	61.60%-6.23M	45.40%-9.35M	-287.10%-79.26M	-165.00%-54.61M	-73.10%8.69M	-166.87%-16.22M
-Change in receivables	0.59%8.58M	-1,254.48%-150.68M	-134.38%-44.06M	-406.97%-75.28M	-3,084.96%-39.88M	42.36%8.53M	-61.68%13.05M	-240.91%-18.8M	347.56%24.52M	194.08%1.34M
-Change in inventory	-328.87%-11.46M	1.30%-46.73M	-20.44%-11.79M	17.67%-19.23M	-16.04%-13.04M	9.82%-2.67M	-657.20%-47.35M	-6.56%-9.79M	-443.63%-23.35M	-249.52%-11.24M
-Change in prepaid assets	31.78%5.16M	203.08%18.18M	83.46%3.37M	149.25%9.72M	-84.72%1.17M	153.06%3.92M	-1,058.11%-17.64M	-69.11%1.84M	-215.74%-19.74M	492.64%7.65M
-Change in payables and accrued expense	35.98%-12.24M	621.21%142.41M	311.21%58.85M	109.62%57.16M	425.95%45.53M	-49.84%-19.12M	-269.98%-27.32M	9.28%-27.86M	3.70%27.27M	-182.79%-13.97M
-Change in other working capital	---1.42M	----	----	----	----	----	----	----	----	----
Cash from discontinued investing activities
Operating cash flow	31.96%-46.77M	27.47%-174.88M	87.06%-12.94M	-46.40%-54.3M	22.23%-38.92M	-27.18%-68.73M	-544.17%-241.12M	-91.03%-99.95M	-370.51%-37.09M	-26,515.43%-50.04M
Investing cash flow
Cash flow from continuing investing activities	1,056.93%202.76M	186.69%144.64M	127.10%35.2M	11,160.39%50.55M	4,800.57%41.37M	149.21%17.53M	-20.55%-166.85M	-220.85%-129.9M	-102.86%-457K	-103.73%-880K
Net PPE purchase and sale	----	127.42%559K	148.28%42K	133.04%151K	----	----	-58.18%-2.04M	81.41%-87K	-75.10%-457K	-112.05%-880K
Net business purchase and sale	----	--7M	--0	----	----	----	--0	--0	----	----
Net investment purchase and sale	-14.93%14.89M	208.44%138.14M	128.43%36.21M	--43.4M	--41.03M	--17.5M	-11,263.25%-127.38M	-217.99%-127.38M	--0	--0
Net other investing changes	722,496.15%187.88M	97.19%-1.05M	----	----	----	100.07%26K	72.48%-37.43M	---2.43M	--0	--0
Cash from discontinued investing activities
Investing cash flow	1,056.93%202.76M	186.69%144.64M	127.10%35.2M	11,160.39%50.55M	4,800.57%41.37M	149.21%17.53M	-20.55%-166.85M	-220.85%-129.9M	-102.86%-457K	-103.73%-880K
Financing cash flow
Cash flow from continuing financing activities	-76.68%887K	28.12%69.6M	-94.45%366K	-77.28%11.11M	7,434.67%54.33M	305.07%3.8M	4.72%54.33M	343.38%6.59M	4,338.42%48.87M	-98.46%721K
Net issuance payments of debt	----	--0	--0	--0	----	----	--49.93M	--0	--49.49M	--0
Net common stock issuance	-77.95%1.51M	1,028.00%71.72M	-101.65%-105K	--11.44M	--53.55M	--6.84M	-84.46%6.36M	--6.36M	--0	--0
Proceeds from stock option exercised by employees	182.52%291K	-16.87%2.5M	37.38%996K	-32.91%53K	-18.76%1.35M	-81.07%103K	-77.53%3.01M	-57.10%725K	-93.83%79K	-72.75%1.66M
Net other financing activities	70.93%-911K	7.06%-4.62M	-7.14%-525K	45.08%-385K	38.75%-577K	-10.39%-3.13M	-105.03%-4.97M	-141.38%-490K	-291.62%-701K	-515.69%-942K
Cash from discontinued financing activities
Financing cash flow	-76.68%887K	28.12%69.6M	-94.45%366K	-77.28%11.11M	7,434.67%54.33M	305.07%3.8M	4.72%54.33M	343.38%6.59M	4,338.42%48.87M	-98.46%721K
Net cash flow
Beginning cash position	61.51%103.34M	-84.68%63.99M	-71.90%80.71M	-73.41%73.36M	-94.91%16.59M	-84.68%63.99M	-22.89%417.64M	-20.43%287.25M	-16.43%275.92M	25.47%326.12M
Current changes in cash	430.96%156.88M	111.13%39.36M	110.14%22.63M	-35.07%7.35M	213.11%56.78M	48.20%-47.4M	-185.29%-353.65M	-494.07%-223.26M	-63.25%11.32M	-171.45%-50.2M
End cash Position	1,469.05%260.23M	61.51%103.34M	61.51%103.34M	-71.90%80.71M	-73.41%73.36M	-94.91%16.59M	-84.68%63.99M	-84.68%63.99M	-20.43%287.25M	-16.43%275.92M
Free cash flow	31.96%-46.77M	27.96%-175.17M	87.03%-12.97M	-44.62%-54.3M	23.08%-39.17M	-25.74%-68.73M	-527.99%-243.16M	-89.51%-100.04M	-379.15%-37.55M	-8,343.95%-50.92M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall